PLX Company Profile and Key Details

Q: Who are the executives of PLX?

Ms. Yael FellousVice President of HRMr. Yaron NaosSenior Vice President of OperationsMr. Dror BashanPres, Chief Executive Officer & DirectorMr. Eyal Rubin M.B.A.Senior Vice President, Chief Financial Officer, Treasurer & Corporation Sec.

AMEX : PLX

Protalix BioTherapeutics

$2.59

0.005+0.19%

At Close 4:00 PM

62.77

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Protalix BioTherapeutics, Inc. (PLX) stock surged +0.19%, trading at $2.59 on AMEX, up from the previous close of $2.59. The stock opened at $2.63, fluctuating between $2.59 and $2.64 in the recent session.

Stock Snapshot

2.585

Prev. Close

208.68M

Market Cap

2.585

Day Low

11.26

P/E Ratio

0.23

EPS (TTM)

-0.03

Cash Flow per Share

2.63

Open

80.57M

Number of Shares

2.64

Day High

95.35%

Free Float in %

0.46

Book Value

454.86K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 02, 2026	2.59	2.64	2.59	2.59	454.86K
Sep 01, 2026	2.61	2.67	2.57	2.59	598.25K
Aug 31, 2026	2.55	2.61	2.53	2.57	747.63K
Aug 28, 2026	2.61	2.62	2.53	2.54	490.23K
Aug 27, 2026	2.49	2.65	2.48	2.61	1.29M
Aug 26, 2026	2.39	2.48	2.36	2.48	1.02M
Aug 25, 2026	2.43	2.43	2.38	2.40	497.74K
Aug 24, 2026	2.36	2.43	2.34	2.41	409.88K
Aug 21, 2026	2.39	2.44	2.35	2.38	647.73K
Aug 20, 2026	2.32	2.39	2.31	2.38	383.48K
Aug 19, 2026	2.37	2.38	2.31	2.35	477.24K
Aug 18, 2026	2.30	2.35	2.28	2.34	280.23K
Aug 17, 2026	2.24	2.37	2.22	2.29	1.08M
Aug 14, 2026	2.36	2.36	2.17	2.22	995.47K
Aug 13, 2026	2.64	2.64	2.32	2.36	1.95M
Aug 12, 2026	2.49	2.71	2.40	2.62	2.01M
Aug 11, 2026	2.47	2.48	2.41	2.43	373.68K
Aug 10, 2026	2.48	2.50	2.41	2.48	773.4K
Aug 07, 2026	2.43	2.47	2.42	2.46	666.06K
Aug 06, 2026	2.44	2.48	2.42	2.44	530.58K

Contact Details

Hackensack, NJ 07601

United States

https://www.protalix.com 201 696 9345

About Company

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics, Inc. has strategic partnership with Secarna Pharmaceuticals GmbH & Co KG. The company is headquartered in Hackensack. New Jersey.

Stock Peers

PTHS

0.21+0.85%

Pelthos Therapeutics Inc.$25.03 AGE

-1.5-11.90%

AgeX Therapeutics, Inc.$11.10 CYBN

0.1+1.22%

Cybin Inc.$8.28 NRXS

0.14+2.41%

NeurAxis, Inc.$5.95 ARMP

0.25+4.73%

Armata Pharmaceuticals, Inc.$5.53 APUS

-0.91-25.71%

Apimeds Pharmaceuticals US, Inc$2.63 SER

0.12+4.80%

Serina Therapeutics, Inc.$2.62 CANF

-0.93-28.27%

Can-Fite BioPharma Ltd.$2.36 OSTX

0.05+3.01%

OS Therapies Incorporated$1.71 CVM

0.04+2.48%

CEL-SCI Corporation$1.65

Frequently Asked Questions

What is the current Protalix BioTherapeutics, Inc. (PLX) stock price?

Protalix BioTherapeutics, Inc. (AMEX: PLX) stock price is $2.59 in the last trading session. During the trading session, PLX stock reached the peak price of $2.64 while $2.59 was the lowest point it dropped to. The percentage change in PLX stock occurred in the recent session was 0.19% while the dollar amount for the price change in PLX stock was $0.01.

PLX's industry and sector of operation?

The AMEX listed PLX is part of Biotechnology industry that operates in the broader Healthcare sector. Protalix BioTherapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PLX?

Ms. Yael Fellous
Vice President of HR
Mr. Yaron Naos
Senior Vice President of Operations
Mr. Dror Bashan
Pres, Chief Executive Officer & Director
Mr. Eyal Rubin M.B.A.
Senior Vice President, Chief Financial Officer, Treasurer & Corporation Sec.

How PLX did perform over past 52-week?

PLX's closing price is 70.39% higher than its 52-week low of $1.52 where as its distance from 52-week high of $3.19 is -18.81%.

How many employees does PLX have?

Number of PLX employees currently stands at 226.

Link for PLX official website?

Official Website of PLX is: https://www.protalix.com

How do I contact PLX?

PLX could be contacted at phone 201 696 9345 and can also be accessed through its website. PLX operates from 2 University Plaza, Hackensack, NJ 07601, United States.

How many shares of PLX are traded daily?

PLX stock volume for the day was 454.86K shares. The average number of PLX shares traded daily for last 3 months was 675.06K.

What is the market cap of PLX currently?

The market value of PLX currently stands at $208.68M with its latest stock price at $2.59 and 80.57M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	226
Beta	0.01
Sales or Revenue	$65.49M
5Y Sales Change%	-0.583%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	226
Beta	0.01
Sales or Revenue	$65.49M
5Y Sales Change%	-0.583%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

PLX Company Profile and Key Details

Protalix BioTherapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Technical Performance

Valuation Metrics

Key Takeaways

Price Forecast & Outlook